Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2011-09-22

Clinical Trial Update: Minimized Time to Beam in Patients With High Grade Gliomas [NA]

View source ↗

Summary

The clinical trial NCT00469534 evaluating minimizing time to beam in patients with high-grade glioma has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Alberta Health services | Conditions: High Grade Glioma | NA | Status: WITHDRAWN